Works matching DE "PROGRAMMED death-ligand 1"

Results: 3861

Faecalibacterium prausnitzii promotes anti-PD-L1 efficacy in natural killer/T-cell lymphoma by enhancing antitumor immunity.

Published in:

BMC Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12916-025-04230-8

By:

Shi, Zhuangzhuang;
Jiang, Wenxing;
Li, Hongwen;
Zhang, Yue;
Xue, Weili;
Wang, Yingjun;
Zhang, Mingzhi;
Li, Zhaoming

Publication type:

Article

Long-term efficacy and updated survival outcomes of sintilimab plus anlotinib in patients with PD-L1-positive recurrent or metastatic cervical cancer.

Published in:

BMC Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12916-025-04198-5

By:

Liu, Jing;
Lan, Chunyan;
Liu, Tongyu;
Liu, Qin;
Chang, Lele;
Zang, Lele;
Zhu, Fei;
Zhu, Mingxuan;
Zhang, Huiqi;
Kang, Yaxin;
Wang, Yuqin;
Lu, Huaiwu;
Sun, Yang;
Xu, Qin

Publication type:

Article

Neoadjuvant chemoradiotherapy with or without PD-1/PD-L1 inhibitors in locally advanced rectal cancer: a systematic review and meta-analysis.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14482-5

By:

Ansab, Muhammad;
Razi, Sepideh;
Nisa, Farwa;
Araib, Eiman;
Rath, Shree;
Khan, Iqra;
Ramzan, Noor Ul Huda;
Dilawar, Esha;
Saeed, Anwaar

Publication type:

Article

Efficacy and safety outcomes of PD-1/PD-L1 inhibitors in recurrent cholangiocarcinoma: a real-world, multicenter and retrospective study.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14459-4

By:

Lin, Lihui;
Lin, Yansong;
Chen, Wei;
Yang, Xia;
Guo, Xianwen;
Wu, Yanqin;
Yin, Xiaoyu;
Ding, Zhen;
Yun, Jingping

Publication type:

Article

Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study.

Published in:

Liver International, 2025, v. 45, n. 7, p. 1, doi. 10.1111/liv.70192

By:

Hatanaka, Takeshi;
Yata, Yutaka;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Kakizaki, Satoru;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Toyoda, Hidenori;
Koshiyama, Yuichi;
Ogawa, Chikara;
Nishikawa, Hiroki;
Nishimura, Takashi

Publication type:

Article

Deciphering cardiotoxicity in PD-1/PD-L1 inhibitor treatment.

Published in:

Central European Journal of Immunology, 2025, v. 50, n. 1, p. 2, doi. 10.5114/ceji.2025.151335

By:

Tabarkiewicz, Jacek;
Głodkowska-Mrówka, Eliza;
Eljaszewicz, Andrzej

Publication type:

Article

The Versatile Role of Period Circadian Regulators (PERs) in Oral Squamous Cell Carcinoma.

Published in:

Biocell, 2025, v. 49, n. 6, p. 961, doi. 10.32604/biocell.2025.062918

By:

Huang, Mei;
Zhang, Zhenyu;
Luo, Yuqi;
Wu, Yuqi;
Pan, Dan;
Zhou, Yu;
Luo, Xiaobo;
Jiang, Yuchen

Publication type:

Article

Artificial Intelligence (AI) for Programmed Death Ligand-1 (PD-L1) Immunohistochemical Assessment in Urothelial Carcinomas: "Teaching" Cell Differentiation to AI Systems.

Published in:

Life (2075-1729), 2025, v. 15, n. 6, p. 839, doi. 10.3390/life15060839

By:

Nechifor-Boilă, Ioan Alin;
Nechifor-Boilă, Adela;
Loghin, Andrada;
Mihu, Carmen Mihaela;
Melincovici, Carmen Stanca;
Onofrei, Mădălin Mihai;
Chibelean, Călin Bogdan;
Martha, Orsolya;
Borda, Angela

Publication type:

Article

PD-1/PD-L1 inhibitor-induced hyponatremia: a real-world pharmacovigilance analysis using FAERS database.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1561942

By:

Tao, Chao;
Liu, Bingyao;
Dai, Yan;
Lv, Jinyi;
He, Huanhuan;
Ding, Qian;
Chen, Kun;
Wang, Ke;
Yang, Liuxuan;
Ren, Xiaoqun;
Zhou, Meiling

Publication type:

Article

High PD-L1 Expression in HRS Cells and Macrophages in Tumor Immune Microenvironment Is Associated with Adverse Outcome and EBV Positivity in Classical Hodgkin Lymphoma.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 12, p. 5592, doi. 10.3390/ijms26125592

By:

Miljak, Antonija;
Pavlović, Antonia;
Benzon, Benjamin;
Čutura, Lučana Vicelić;
Galušić, Davor;
Vujčić, Milan;
Blaslov, Viktor;
Durdov, Merica Glavina

Publication type:

Article

The role of tumor-associated macrophages and PD-1/PD-L1 networking in colorectal cancer.

Published in:

Contemporary Oncology / Współczesna Onkologia, 2025, v. 29, n. 2, p. 123, doi. 10.5114/wo.2025.150448

By:

Yerolatsite, Melina;
Torounidou, Nanteznta;
Amylidi, Anna-Lea;
Zarkavelis, George;
Hadjigeorgiou, Loizos;
Lampri, Evangeli;
Bali, Christina;
Georvasili, Vaia;
Kampletsas, Eleftherios;
Mauri, Davide

Publication type:

Article

Aurantio-obtusin modulates Wilms Tumour 1 within the breast tumour microenvironment reducing immunosuppression and tumour growth.

Published in:

Cell Communication & Signaling, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12964-025-02292-y

By:

Li, Rui;
O'Connor, Dómhnall J;
Digby, Barry;
Broin, Pilib Ó.;
Hu, Xiao;
Ge, Ning;
Loftus, Paul G.;
Kumar, Vatsal;
McEvoy, Eoin;
Elliman, Stephen J.;
Kerin, Michael J.;
Barkley, Laura R.

Publication type:

Article

The distribution characteristics of PD-1 pathway-related immune cells in esophageal cancer tissue and their prognostic significance.

Published in:

PLoS ONE, 2025, v. 20, n. 6, p. 1, doi. 10.1371/journal.pone.0325349

By:

Kong, Dehua;
Gao, Chunyan;
Yu, Yang;
Yang, Lu;
Ma, Ji;
Tang, Shimin;
Mao, Ying;
Li, Yong;
Li, Na

Publication type:

Article

δ‐Tocotrienol Potentiates Breast and Prostate Cancer Cells to Paclitaxel via Suppressing PD‐L1‐Mediated Cancer‐Promoting Signaling.

Published in:

Chemical Biology & Drug Design, 2025, v. 105, n. 6, p. 1, doi. 10.1111/cbdd.70143

By:

Sun, Zhenou;
Ma, Xuan;
Li, Jiaxuan;
Fan, Lihong;
Zhao, Chong;
Yin, Shutao;
Hu, Hongbo

Publication type:

Article

Cosibelimab.

Published in:: American Journal of Health-System Pharmacy, 2025, v. 82, n. 13, p. 638, doi. 10.1093/ajhp/zxaf055
Publication type:: Article

Recent Advances of Shikonin in the Molecular Mechanisms of Anticancer, Anti-Inflammation and Immunoregulation.

Published in:

American Journal of Chinese Medicine, 2025, v. 53, n. 4, p. 1093, doi. 10.1142/S0192415X25500417

By:

Ye, Xiaoyun;
Wu, Xiaohong;
Lian, Siheng;
Cai, Ruina;
Wei, Xianni;
Nan, Tingting;
Cai, Yumei;
Su, Yonglong;
Wei, Jinbao

Publication type:

Article

Synthesis and In Vitro Evaluation of a Scandium-44 Radiolabeled Nanobody as a PD-L1 PET Imaging Probe.

Published in:

Pharmaceutics, 2025, v. 17, n. 6, p. 796, doi. 10.3390/pharmaceutics17060796

By:

Krol, Viktoria E.;
Bansal, Aditya;
Kethamreddy, Manasa;
Ellinghuysen, Jason R.;
Vail, Daniel J.;
Lucien-Matteoni, Fabrice;
Dong, Haidong;
Park, Sean S.;
Pandey, Mukesh K.

Publication type:

Article

Mini‐review: Immunology in ovarian cancer.

Published in:

Journal of Obstetrics & Gynaecology Research, 2023, v. 49, n. 9, p. 2245, doi. 10.1111/jog.15730

By:

Taki, Mana

Publication type:

Article

Retraction Note: miR-34a attenuates glioma cells progression and chemoresistance via targeting PD-L1.

Published in:

2023

By:

Wang, Yi;
Wang, Li

Publication type:

Correction Notice

BMSCs improve TNBS-induced colitis in rats by inducing Treg differentiation by expressing PD-L1.

Published in:

Biotechnology Letters, 2022, v. 44, n. 11, p. 1263, doi. 10.1007/s10529-022-03307-1

By:

Gao, Fei;
Cui, Dandan;
Zuo, Dongmei;
Shou, Zhexing;
Yang, Jia;
Yu, Ting;
Liu, Yujin;
Chu, Si;
Zhu, Feng;
Wei, Chunzhu

Publication type:

Article

Hsp90 up-regulates PD-L1 to promote HPV-positive cervical cancer via HER2/PI3K/AKT pathway.

Published in:

Molecular Medicine, 2021, v. 27, n. 1, p. 1, doi. 10.1186/s10020-021-00384-2

By:

Zeng, Jie;
He, Si-Li;
Li, Li-Jie;
Wang, Chen

Publication type:

Article

Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer.

Published in:

Molecular Medicine, 2020, v. 26, n. 1, p. 1, doi. 10.1186/s10020-020-00208-9

By:

Sun, Dantong;
Tian, Lu;
Zhu, Yan;
Wo, Yang;
Liu, Qiaoling;
Liu, Shihai;
Li, Hong;
Hou, Helei

Publication type:

Article

miR‐186‐5p Down‐Regulates PD‐L1 Level in Acute Myeloid Leukemia Cells and Inhibits Tumorigenesis and Immune Escape.

Published in:

Journal of Biochemical & Molecular Toxicology, 2025, v. 39, n. 5, p. 1, doi. 10.1002/jbt.70278

By:

Lian, Cheng;
Liu, Yanhui;
Lei, Pingchong

Publication type:

Article

Cancer‐associated fibroblasts‐derived exosomal ZNF250 promotes the proliferation, migration, invasion, and immune escape of hepatocellular carcinoma cells by transcriptionally activating PD‐L1.

Published in:

Journal of Biochemical & Molecular Toxicology, 2024, v. 38, n. 9, p. 1, doi. 10.1002/jbt.23778

By:

Feng, Huizhi;
Liu, Jingmei;
Jia, Haixia;
Bu, Xiaoqian;
Yang, Wenhui;
Su, Peng

Publication type:

Article

Bakuchiol inhibits lung cancer by modulating tumor microenvironment and the expression of PD‐L1.

Published in:

Journal of Biochemical & Molecular Toxicology, 2023, v. 37, n. 9, p. 1, doi. 10.1002/jbt.23401

By:

Lin, Mengxin;
Xu, Qian;
Luo, Yang;
Liu, Gaohua;
Hou, Peifeng

Publication type:

Article

Inhibition of NF‐κB is required for oleanolic acid to downregulate PD‐L1 by promoting DNA demethylation in gastric cancer cells.

Published in:

Journal of Biochemical & Molecular Toxicology, 2021, v. 35, n. 1, p. 1, doi. 10.1002/jbt.22621

By:

Lu, Xirong;
Li, Yuyi;
Yang, Wei;
Tao, Minghao;
Dai, Yanmiao;
Xu, Jinkang;
Xu, Qianfei

Publication type:

Article

Synergistic effects of BTN3A1, SHP2, CD274, and STAT3 gene polymorphisms on the risk of systemic lupus erythematosus: a multifactorial dimensional reduction analysis.

Published in:

Clinical Rheumatology, 2024, v. 43, n. 1, p. 489, doi. 10.1007/s10067-023-06765-8

By:

Tang, Yang-Yang;
Xu, Wang-Dong;
Fu, Lu;
Liu, Xiao-Yan;
Huang, An-Fang

Publication type:

Article

PD-L1 expression in high-risk non-muscle invasive bladder cancer is not a biomarker of response to BCG.

Published in:

World Journal of Urology, 2025, v. 43, n. 1, p. 1, doi. 10.1007/s00345-024-05392-5

By:

de Jong, Florus C.;
Kvikstad, Vebjørn;
Hoedemaeker, Robert F.;
van der Made, Angelique C. J.;
van der Bosch, Thierry P.;
van Casteren, Niels J.;
van Kessel, Kim E. M.;
Zwarthoff, Ellen C.;
Boormans, Joost L.;
Zuiverloon, Tahlita C. M.

Publication type:

Article

High programmed death ligand 1 expression in carcinomatous components predicts a poor prognosis in pulmonary pleomorphic carcinoma.

Published in:

Surgery Today, 2022, v. 52, n. 7, p. 1090, doi. 10.1007/s00595-021-02439-7

By:

Noguchi, Misa;
Menju, Toshi;
Nakajima, Naoki;
Yoshizawa, Akihiko;
Ohsumi, Akihiro;
Nakajima, Daisuke;
Hamaji, Masatsugu;
Haga, Hironori;
Date, Hiroshi

Publication type:

Article

Reply to the letter.

Published in:

2020

By:

Okabe, Hirohisa;
Yamashita, Yo-ichi;
Elmezayen, Hatem A.;
Hayashi, Hiromitsu;
Imai, Katsunori;
Baba, Hideo

Publication type:

Letter

PD-L1, fibrosis, and immunotherapy in hepatocellular carcinoma: the importance of a scientific method to explore observations and answer questions.

Published in:

2020

By:

Grizzi, Fabio;
Qehajaj, Dorina;
Yiu, Daniel;
Bresalier, Robert S.;
Chiriva-Internati, Maurizio

Publication type:

Letter

Prognostic impact of CD8+ T cell distribution and its association with the HLA class I expression in intrahepatic cholangiocarcinoma.

Published in:

Surgery Today, 2020, v. 50, n. 8, p. 931, doi. 10.1007/s00595-020-01967-y

By:

Asahi, Yoh;
Hatanaka, Kanako C.;
Hatanaka, Yutaka;
Kamiyama, Toshiya;
Orimo, Tatsuya;
Shimada, Shingo;
Nagatsu, Akihisa;
Sakamoto, Yuzuru;
Kamachi, Hirofumi;
Kobayashi, Nozomi;
Fukai, Moto;
Taketomi, Akinobu

Publication type:

Article

Prediction of immunotherapy response in nasopharyngeal carcinoma: a comparative study using MRI-based radiomics signature and programmed cell death ligand 1 expression score.

Published in:

European Radiology, 2025, v. 35, n. 7, p. 4403, doi. 10.1007/s00330-025-11350-5

By:

Mai, Hui;
Li, Li;
Xin, Xin;
Jiang, Zhike;
Tang, Yongfang;
Huang, Jie;
Lei, Yanxing;
Chen, Lianzhi;
Dong, Tianfa;
Zhong, Xi

Publication type:

Article

Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([<sup>18</sup>F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer.

Published in:

European Radiology, 2024, v. 34, n. 9, p. 5889, doi. 10.1007/s00330-024-10651-5

By:

Hughes, Daniel Johnathan;
Josephides, Eleni;
O'Shea, Robert;
Manickavasagar, Thubeena;
Horst, Carolyn;
Hunter, Sarah;
Tanière, Philippe;
Nonaka, Daisuke;
Van Hemelrijck, Mieke;
Spicer, James;
Goh, Vicky;
Bille, Andrea;
Karapanagiotou, Eleni;
Cook, Gary J. R.

Publication type:

Article

A multiparametric approach to predict triple-negative breast cancer including parameters derived from ultrafast dynamic contrast-enhanced MRI.

Published in:

European Radiology, 2023, v. 33, n. 11, p. 8132, doi. 10.1007/s00330-023-09730-w

By:

Ohashi, Akane;
Kataoka, Masako;
Iima, Mami;
Honda, Maya;
Ota, Rie;
Urushibata, Yuta;
Dominik Nickel, Marcel;
Toi, Masakazu;
Zackrisson, Sophia;
Nakamoto, Yuji

Publication type:

Article

MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinoma.

Published in:

2020

By:

Hectors, Stefanie J.;
Lewis, Sara;
Besa, Cecilia;
King, Michael J.;
Said, Daniela;
Putra, Juan;
Ward, Stephen;
Higashi, Takaaki;
Thung, Swan;
Yao, Shen;
Laface, Ilaria;
Schwartz, Myron;
Gnjatic, Sacha;
Merad, Miriam;
Hoshida, Yujin;
Taouli, Bachir

Publication type:

journal article

The Immune Microenvironment in Prostate Cancer: A Comprehensive Review.

Published in:

Oncology, 2025, v. 103, n. 6, p. 521, doi. 10.1159/000541881

By:

Novysedlak, Rene;
Guney, Miray;
Al Khouri, Majd;
Bartolini, Robin;
Koumbas Foley, Lily;
Benesova, Iva;
Ozaniak, Andrej;
Novak, Vojtech;
Vesely, Stepan;
Pacas, Pavel;
Buchler, Tomas;
Ozaniak Strizova, Zuzana

Publication type:

Article

Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma.

Published in:

Oncology, 2025, v. 103, n. 6, p. 490, doi. 10.1159/000541250

By:

LaPelusa, Michael;
Chamseddine, Shadi;
Tran Cao, Hop Sanderson;
Xiao, Lianchun;
Hasanov, Elshad;
Bhosale, Priya;
Amin, Hesham M.;
Mohamed, Yehia I.;
Gok Yavuz, Betul;
Sakr, Yara;
Xu, Li;
Hu, Ian;
Lee, Sunyoung S.;
Sakamuri, Divya;
Jindal, Sonali;
Nguyen, Van;
Curran, Michael A.;
Sun, Ryan;
Rashid, Asif;
Duda, Dan Gabriel

Publication type:

Article

Pulmonary Adenocarcinoma with Enteric Differentiation without TTF-1 Expression Is a Very Rare Subtype with Limited Treatment Options and Poor Prognosis.

Published in:

Oncology, 2025, v. 103, n. 3, p. 179, doi. 10.1159/000540515

By:

Kraus, Franziska Maria;
Traut, Alexander;
Nilius, Georg;
Volmerig, Jan;
Koziorowski, Andreas;
Stöver, Imke;
Grabellus, Florian;
Stahl, Michael;
Christoph, Daniel C.

Publication type:

Article

Remaining Issues Related to Serum Cytokines in Patients with Unresectable Hepatocellular Carcinoma Treated by Atezolizumab plus Bevacizumab Combination Treatment.

Published in:

Oncology, 2024, v. 102, n. 10, p. 828, doi. 10.1159/000537965

By:

Nagai, Hidenari;
Mukozu, Takanori;
Matsui, Teppei;
Mohri, Kunihide;
Nagumo, Hideki;
Yoshimine, Naoyuki;
Kobayashi, Kojiro;
Ogino, Yu;
Daido, Yasuko;
Wakui, Noritaka;
Momiyama, Koichi;
Matsuda, Takahisa;
Igarashi, Yoshinori;
Higai, Koji

Publication type:

Article

Variations in Patterns of Prescribing Durvalumab in Stage III Lung Cancer: A Survey of Australian Medical Oncologists.

Published in:

Oncology, 2024, v. 102, n. 8, p. 732, doi. 10.1159/000535855

By:

Nindra, Udit;
Bray, Victoria;
Karikios, Deme;
Shafiei, Mohsen;
Subramaniam, Shalini;
Ding, Pei;
Kao, Steven;
Pal, Abhijit

Publication type:

Article

RNA Expression-Based Analysis to Predict Response in Patients with Metastatic Mismatch Repair Proficient Colorectal Cancer Treated with Regorafenib and Nivolumab.

Published in:

Oncology, 2024, v. 102, n. 7, p. 549, doi. 10.1159/000535599

By:

Miao, Ruoyu;
Kim, Dae Won;
Yu, James;
Malafa, Mokenge;
Mehta, Rutika;
Strosberg, Jonathan;
Imanirad, Iman;
Iyer, Seema;
Uhlik, Mark;
Benjamin, Laura;
Kim, Richard

Publication type:

Article

Clinical Utility of Inflammatory and Nutritious Index as Therapeutic Prediction of Nivolumab plus Ipilimumab in Advanced Non-Small Cell Lung Cancer.

Published in:

Oncology, 2024, v. 102, n. 3, p. 271, doi. 10.1159/000534169

By:

Yamaguchi, Ou;
Kaira, Kyoichi;
Imai, Hisao;
Mouri, Atsuto;
Shiono, Ayako;
Miura, Yu;
Hashimoto, Kosuke;
Kobayashi, Kunihiko;
Kagamu, Hiroshi

Publication type:

Article

The Balance of CD8-Positive T Cells and PD-L1 Expression in the Myocardium Predicts Prognosis in Lymphocytic Fulminant Myocarditis.

Published in:

Cardiology, 2024, v. 149, n. 1, p. 28, doi. 10.1159/000534518

By:

Hiraiwa, Hiroaki;
Morimoto, Ryota;
Tsuyuki, Yuta;
Ushida, Kaori;
Ito, Ryota;
Kazama, Shingo;
Kimura, Yuki;
Araki, Takashi;
Mizutani, Takashi;
Oishi, Hideo;
Kuwayama, Tasuku;
Kondo, Toru;
Okumura, Takahiro;
Murohara, Toyoaki

Publication type:

Article

A Rare Case of NUT Carcinoma of the Thyroid.

Published in:

JCEM Case Reports, 2024, v. 2, n. 3, p. 1, doi. 10.1210/jcemcr/luae037

By:

Cadesky, Adam;
Schulman-Rosenbaum, Rifka;
Carter, Amanda;
Paul, Elizabeth;
Jaggi, Shuchie

Publication type:

Article

Iatrogenic Pituitary Shutdown: A Rare Adverse Event of Programmed Cell Death-Ligand 1 Inhibitor.

Published in:

JCEM Case Reports, 2024, v. 2, n. 1, p. 1, doi. 10.1210/jcemcr/luad157

By:

Al-Hiari, Mohammed;
Workman, Anthony;
Ezeh, Ebubechukwu;
Teka, Samson

Publication type:

Article

Hyperprogressive disease induced by PD-1 inhibitor monotherapy in lung adenocarcinoma with HER2 exon 20 insertion: report of two cases and review of literature.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-01749-3

By:

Yang, Guangjian;
Tian, Linyan;
Wang, Yan

Publication type:

Article

Genomic and immunological profiling reveals novel prognostic biomarkers for limited-stage small cell lung cancer.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02925-1

By:

Li, Ye;
Ma, Xiaolong;
Wan, Zhiyi;
Bao, Pengfei;
Zhang, Enli;
Liu, Lihua;
Jiao, Shunchang;
Sun, Shengjie

Publication type:

Article

Identification of PD-L1-related biomarkers for selecting gastric adenocarcinoma patients for PD-1/PD-L1 inhibitor therapy.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02515-1

By:

Li, Bo-Ya;
Li, Hui-Ling;
Zeng, Fei-Er;
Luan, Xuan-Yu;
Liu, Bi-Qing;
Wang, Zhi-Zhou;
Zhang, Lan;
Dong, Xian-Zhe

Publication type:

Article

Metformin induces apoptosis in pituitary-derived folliculostellate cells via the IL-6/ERK pathway.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02372-y

By:

Wang, Xin;
Li, Siyuan;
Fan, Dong;
Luo, Yuyou;
Chen, Huitong;
Wang, Zhongyu;
Yuan, Xingyi;
Liu, Jing;
Wang, Zongming

Publication type:

Article